Among partial nicotine receptor agonists,evidence suggests that smokers using _______ increase their chances of quitting by two to three times in comparison to those who try to quit with no other assistance.
A)bupropion (Wellbutrin)
B)dianicline
C)cytisine
D)varenicline (Chantix)

Question

Quizplus · Accepted Answer

Among partial nicotine receptor agonists, varenicline (Chantix) has the strongest evidence to support its efficacy in aiding smoking cessation, with studies showing that smokers using varenicline can increase their chances of quitting by two to three times in comparison to those who try to quit with no other assistance. Bupropion (Wellbutrin) is also a partial nicotine receptor agonist that is FDA-approved for smoking cessation, but its efficacy is not as strong as varenicline. Dianicline and cytisine are also partial nicotine receptor agonists, but they are not FDA-approved for smoking cessation in the United States and have more limited evidence to support their efficacy.

Among Partial Nicotine Receptor Agonists,evidence Suggests That Smokers Using _______